3D printing makes its way into cancer research lab

Bioprinting company Organovo today announced a collaboration with Oregon Health & Science University�s Knight Cancer Institute in which it will create 3D models of breast and pancreatic tumors for researchers to use in drug discovery and development. MedCity News reports via @Info3Dprinter.

... Today, researchers use animal models and cell lines to identify and test potential new drugs. Having more robust, 3D disease models for what Carroll called �preclinical-plus� testing could give researchers better insight into how tumors behave and how they respond to drugs.

Read full article. Organovo press release.